Načítá se...
An analysis of redactions in Canada’s Common Drug Review Clinical Review Reports and how they relate to the patients’ voice
IMPORTANCE: Canada’s Common Drug Review (CDR) evaluates drug data from published and unpublished research, as well as input from patient groups, to recommend provincial coverage. Currently, the CDR process gives manufacturers the opportunity to redact information in the final publicly available repo...
Uloženo v:
| Vydáno v: | BMJ Open |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5595205/ https://ncbi.nlm.nih.gov/pubmed/28893743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-015497 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|